Skip to content

Bio-Techne TECH Price / book

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Danaher logo
DanaherDHR
2.5×-0.4×
Bruker logo
BrukerBRKR
2.2×-1.2×
Revvity logo
RevvityRVTY
1.4×-0.3×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
1.1×+0.1×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Calculated from Bio-Techne’s reported figures.

Based on the most recent quarter.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's price / book?
Bio-Techne (TECH) reported price / book of 3.9× in Q1 2026.
How has Bio-Techne's price / book changed year-over-year?
Bio-Techne's price / book decreased by 14.6% year-over-year, from 4.6× to 3.9×.
What is the long-term trend for Bio-Techne's price / book?
Over 4 years (2021 to 2025), Bio-Techne's price / book has grown at a -22.5% compound annual growth rate (CAGR), from 11.3× to 4.1×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.